These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34057693)

  • 1. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
    Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
    Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
    Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
    Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature.
    Hua Y; Soni P; Larsen D; Zreik R; Leng B; Rampisela D
    World J Gastroenterol; 2020 Sep; 26(36):5520-5526. PubMed ID: 33024402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
    Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
    Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review.
    Agaimy A; Rau TT; Hartmann A; Stoehr R
    Am J Surg Pathol; 2014 Jul; 38(7):910-20. PubMed ID: 24503755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMARCB1/INI1-Deficient Poorly Differentiated Carcinoma of the Colon With Rhabdoid Features-A Rare Tumor With Serrated Phenotype: Case Report and Review of Literature.
    Maurya S; Yadav S; Bhowmik S; Dhal J; Mehra L; Sharma R; Krishna A; Sharma A; Barwad A; Das P
    Int J Surg Pathol; 2024 Feb; 32(1):187-195. PubMed ID: 37128676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clinicopathologic and molecular spectrum.
    Yin X; Yang X; Wang S; Zhou J; Zhao M
    Ann Diagn Pathol; 2024 Feb; 68():152242. PubMed ID: 38039617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMARCB1 (INI1)-deficient sinonasal carcinoma: a series of 13 cases with assessment of histologic patterns.
    Kakkar A; Antony VM; Pramanik R; Sakthivel P; Singh CA; Jain D
    Hum Pathol; 2019 Jan; 83():59-67. PubMed ID: 30120966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
    Agaimy A
    Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.
    Agaimy A; Koch M; Lell M; Semrau S; Dudek W; Wachter DL; Knöll A; Iro H; Haller F; Hartmann A
    Am J Surg Pathol; 2014 Sep; 38(9):1274-81. PubMed ID: 24832165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
    Kezlarian BE; Lin O; Dogan S
    J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss.
    Agarwal S; Kakkar A; Damle NA; Kumar C; Sarangi J; Subudhi K; Jain D; Sharma MC
    Pathol Res Pract; 2020 Apr; 216(4):152830. PubMed ID: 31982181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCB1/INI1-deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report.
    Fujita K; Mizuguchi K; Mori T; Shimoda T; Sakano K; Shimaguchi C; Ito A; Yoshimura K; Sakaguchi M; Imi T; Ikeda H
    Diagn Cytopathol; 2023 Oct; 51(10):E294-E300. PubMed ID: 37475580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience.
    Bell D; Hanna EY; Agaimy A; Weissferdt A
    Virchows Arch; 2015 Dec; 467(6):649-656. PubMed ID: 26407663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study.
    Espinosa I; D'Angelo E; De Brot L; Prat J
    Hum Pathol; 2023 May; 135():1-10. PubMed ID: 36863690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of retroperitoneal tumor displaying epithelial differentiation, prominent myxoid stroma and loss of INI1/SMARCB1.
    Rekhi B; Thomas A
    Pathologica; 2021 Dec; 113(6):456-462. PubMed ID: 34974552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features.
    Ayyanar P; Mishra P; Preetam C; Adhya AK
    Head Neck Pathol; 2021 Jun; 15(2):555-565. PubMed ID: 33141418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor.
    Duan Z; Yao K; Yang S; Qu Y; Ren M; Zhang Y; Fan T; Zhao H; Gao J; Feng J; Fan X; Qi X
    Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.